Abstract
Acute myeloid leukemia (AML) is a group of hematopoietic neoplasms derived from the bone marrow precursors of the myeloid lineage. The neoplastic process is the result of clonal proliferation of an aberrant, committed stem cell at the level of CFU-S or later stages of differentiation, leading to the accumulation of immature forms without or with limited maturation. Other terms used for AML include acute non-lymphoid leukemia, acute myelogenous leukemia, and acute myeloblastic leukemia.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
